Antidiabetic bicyclic compounds

Details for Australian Patent Application No. 2007314405 (hide)

Owner Merck & Co., Inc.

Inventors Lin, Songnian; Ge, Min; Zhou, Changyou; Walsh, Shawn P.; Yang, Lihu

Agent Spruson & Ferguson

Pub. Number AU-A-2007314405

PCT Pub. Number WO2008/054675

Priority 60/855,727 31.10.06 US

Filing date 26 October 2007

Wipo publication date 8 May 2008

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

C07D 277/14 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 339/02 (2006.01) Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms

Event Publications

30 April 2009 PCT application entered the National Phase

  PCT publication WO2008/054675 Priority application(s): WO2008/054675

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007314433-DNA composition for eliciting an immune response against tumor-associated macrophages

2007314397-Process for forming clear, wettable silicone hydrogel articles